TY  - JOUR
UR  - https://jlsb.science-line.com/attachments/article/81/JLSB%2010(6)%2070-79,%202020-drugs%20and%20vaccine%20candidates%20to%20tackle%20COVID-19%20.pdf
SP  - 70
Y1  - 2020/11/25/
AV  - public
A1  - GHARIB MOMBENI, Ehsan
A1  - YOUSEFI, Mahshad
A1  - CHEKANI-AZAR, Saeid
A1  - ABOUSENNA, Mohamed Samy
A1  - ARMIN, Kosar
A1  - SHAVANDI, Fatemeh
A1  - EMAMI, Elham
A1  - BAHRAMI, Yadollah
KW  - Actemra
KW  -  Antiviral medicines
KW  -  ARCoV
KW  -  AstraZeneca
KW  -  ChulaCov19
KW  -  CoronaVac
KW  -  COVID-19
KW  -  CureVac
KW  -  CytoSorb
KW  -  Ivermectin
KW  -  Moderna
KW  -  Oleandrin
KW  -  Pfizer
KW  -  Remdesivir
KW  -  Ritonavir
KW  -  Vaccines.
EP  - 79
VL  - 10
SN  - 2251-9939
TI  - Recent drugs and vaccine candidates to tackle
COVID-19
N2  - Introduction. The global devastating pandemic coronavirus disease 2019 (COVID-19) is a worldwide multisystemic infection caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged as a menace to the global public health and countries economy. There is a crucial necessity for the suggestion of effective drugs to eliminate the virus outbreak. Several candidate drugs with existing emerging evidence try to offer a pharmacological strategy that may inhibit infection in COVID-19 patients. By, October 2020, scientists have nominated some reliable and safe types of coronavirus vaccines like Pfizer, Moderna, AstraZeneca, CureVac, CoronaVac, etc. that are effective and showed 95% to 90% protection, respectively. Aim. This review highlights important clinical and in vitro studies, uses of potent antiviral drugs and most recent vaccines against COVID-19 disease.
PB  - Scienceline Publications, Ltd
JF  - Journal of Life Science and Biomedicine
IS  - 06
ID  - eprints559
ER  -